Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Michael M. Cubrilo who wrote (2191)	5/14/1998 5:50:00 PM
From: CycloneTech	Respond to of 8117

Newest News Release, Folks! U.S. Military to evaluate F.A.S.T. 1 Pyng Technologies Corp PYT Shares issued 7,677,856 May 13 close $4.50 Thu 14 May 98 News Release Mr. Michael Jacobs, Pyng Technologies Corp. is very pleased to announce that subsidiary Pyng Medical Corp. has received confirmation from the U.S. Military that the F.A.S.T 1 Adult Intraosseous Infusion System developed by Pyng Medical Corp. will undergo a full product evaluation process at Walter Reed Army Institute of Research in Washington, D.C. Pyng Medical Corp. personnel will train appropriate medical personnel from the U.S. Army Special Operations Command including the Chief, Combat Trauma Research in the first week of June. The evaluation process has been requested by United States Army Special Operations Command and will provide the U.S. Military hands on performance verification of the F.A.S.T 1 System by the different groups in the Special Operations Command. The F.A.S.T 1 System is the only FDA approved Intraosseous Infusion System for Adult emergency vascular access and was designed specifically for the battlefield, as well as the pre-hospital and emergency hospital environments. Pyng Medical continues to advance the F.A.S.T 1 System into the military, pre-hospital and emergency hospital markets. Pyng Medical is also pleased to announce that additional use of the F.A.S.T 1 System, this time at the University of Maryland Medical Center in Baltimore, has been confirmed. (c) Copyright 1998 Canjex Publishing Ltd. canada-stockwatch.com